Literature DB >> 17019368

Downregulation of CCR5 expression on cells by recombinant adenovirus containing antisense CCR5, a possible measure to prevent HIV-1 from entering target cells.

Wengang Li1, Min Yu, Li Bai, Dingfang Bu, Xiaoyuan Xu.   

Abstract

Chemokine (C-C motif) receptor 5 (CCR5) is one of the major co-receptors for the macrophage (M)-tropic HIV-1. To prevent HIV-1 from entering into target cells, we inhibited CCR5 expression on target cell surface by recombinant adenovirus containing anti-sense CCR5 cDNA. A fragment of 653 bp cDNA located in the 5' region of CCR5 cDNA was reversely inserted into pAdTrack-CMV. Recombinant adenovirus containing antisense CCR5 cDNA (Ad-antiR5) was obtained by homologous recombination of resultant plasmid with the adenoviral backbone plasmid pAdEasy-2 in E. coli BJ5183 and then packed in AD-293 cells. Rate of positive CCR5 on U937 cell surface measured by flow cytometry was decreased from 89.53% to 1.88% after U937 cells infected with Ad-antiR5 for 24 hours, and this reduction lasted at least for 10 days. After challenged with HIV-1, the U937 cells infected with Ad-antiR5 produced much less p24 antigen in cultured medium than those infected with control recombinant adenovirus and the uninfected cells. The recombinant adenovirus had no effect on chemotactic activity and proliferation of the U937 cells. Therefore, the recombinant adenovirus containing anti-sense CCR5 cDNA can down-regulate CCR5 expression on U937 cells and protect the cells from HIV-1 infection without effects on their chemotaxis activity and proliferation function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019368     DOI: 10.1097/01.qai.0000243102.95640.92

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  4 in total

1.  Transmembrane protein aptamers that inhibit CCR5 expression and HIV coreceptor function.

Authors:  Elizabeth H Scheideman; Sara A Marlatt; Yanhua Xie; Yani Hu; Richard E Sutton; Daniel DiMaio
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 2.  Engineering T Cells to Functionally Cure HIV-1 Infection.

Authors:  Rachel S Leibman; James L Riley
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

3.  Dopamine receptor activation increases HIV entry into primary human macrophages.

Authors:  Peter J Gaskill; Hideaki H Yano; Ganjam V Kalpana; Jonathan A Javitch; Joan W Berman
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 4.  CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.

Authors:  Gero Hütter; Josef Bodor; Scott Ledger; Maureen Boyd; Michelle Millington; Marlene Tsie; Geoff Symonds
Journal:  Viruses       Date:  2015-07-27       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.